Also

Britain’s highest court will hear the appeal by Amgen Inc. of Thousand Oaks in a patent dispute with rival Transkaryotic Therapies Inc. over competing anemia drugs. The House of Lords will review a decision that Transkaryotic’s drug Dynepo does not infringe a patent covering Amgen’s $2-billion treatment Epogen. It also will hear Transkaryotic’s argument that the patent is invalid.

*

* Dynegy Inc. of Houston revised financial statements for the third time since November with $24 million of changes to net income for 2001 and 2000.

The family of a New York state trooper who was killed in December when his Crown Victoria cruiser was hit from behind and burst into flames sued manufacturer Ford Motor Co. for more than $250 million.

*

DaimlerChrysler recalled 1.2 million Dodge and Chrysler sedans in North America because a bolt can wear out and break, causing the front seat to recline unexpectedly while the car is moving, the National Highway Traffic Safety Administration said. The voluntary recall covers 1998 through 2002 models of the Chrysler 300M, Concorde, LHS and Intrepid, as well as the Dodge Intrepid.

*

* Online magazine publisher Salon Media Group Inc., based in San Francisco, warned that it may not survive beyond this month if it can’t raise money to pay its rent and other bills.